Nientzu Ting

Nien-tzu Ting currently serves as a Manager of Clinical Operations (Trial Monitoring Manager) at MorphoSys, where she plays a pivotal role in overseeing the execution of complex clinical trials within the oncology therapeutic area. Leveraging her extensive background in clinical research, patient care, and public health, Nien-tzu is responsible for ensuring the seamless coordination and compliance of global Phase III trials across the Asia-Pacific region. Her expertise in site management, regulatory submissions, and trial monitoring allows her to effectively lead cross-functional teams, including CRO partners, to meet project milestones and uphold the highest standards of Good Clinical Practice (GCP).

In her current role, Nien-tzu manages critical aspects such as developing and implementing monitoring plans, reviewing visit reports, and maintaining Trial Master Files (TMF) to ensure data integrity and regulatory compliance. She actively conducts risk assessments to identify potential site-related issues early, facilitating proactive solutions that minimize trial delays. Her keen attention to detail and strong communication skills enable her to foster productive relationships with investigators and site staff, enhancing patient engagement and retention throughout the trial lifecycle.

Nien-tzu’s expertise extends to feasibility assessments, site qualification, and performance monitoring, which are essential for optimizing trial operations and ensuring high-quality data collection. Her proficiency in regulatory science and experience with international standards position her as a vital contributor to MorphoSys’s strategic goals in advancing innovative oncology treatments. With her comprehensive skill set and dedication to excellence, Nien-tzu continues to drive successful clinical outcomes and support the advancement of groundbreaking therapies in a highly regulated environment.